Creso Pharma (ASX:CPH) share price sinks despite US cannabis update

The Creso Pharma Ltd (ASX:CPH) share price is sinking on Tuesday despite announcing an important appointment in the United States…

| More on:
A white cannabis leaf set against a green background with a graph going up, indicating a rising share price for ASX cannabis shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Creso Pharma Ltd (ASX: CPH) share price has come under pressure today despite the release of a positive announcement.

At the time of writing, the cannabis company's shares are down 5% to 20 cents.

What did Creso Pharma announce?

This morning Creso Pharma announced an important appointment in the United States.

According to the release, the company has named leading cannabis executive John Griese as its Director of US Business Development.

Mr Griese has considerable experience in the cannabis sector through previous roles with Blooms Farms and most recently as the Chief Operating Officer of Supreme Cannabis Company.

With the latter, Mr Griese was directly responsible for product development, commercialisation initiatives, procurement, manufacturing operations, and supply chain management.

The new US Business Development Director has also previously worked for Creso Pharma as its Americas Chief Operating Officer.

Why is Creso Pharma making this appointment?

Creso Pharma made the appointment in response to the global trend towards cannabis legalisation, as well as recent legislation in New York State legalising recreational marijuana.

Mr Griese will focus on New York, Vermont, and other states to delineate a strategy for Creso Pharma to begin delivering products into the USA.

This is certainly a worthwhile endeavour. The release notes that New York State is expected to become one of the largest recreational markets in the US with an estimated market value of US$4.2 billion per annum.

The company notes that its ability to export cannabis products into the USA will remain subject to the federal legalisation of cannabis. However, having Mr Griese commence supply, sale, distribution and partnership agreements now, pending federal legalisation, provides the company with an opportunity to be a first mover in this large market. It also believes it will provide it with a significant competitive advantage over its peers.

Creso's Non-Executive Chairman, Adam Blumenthal, commented: "We are very excited to welcome John back to Creso and Board and management are very confident that his new role will unlock a number of potential opportunities for the Company throughout the US."

"The recent legislative push in New York State highlights the ongoing shift towards the federal legalisation of recreational cannabis and John's appointment shows Creso Pharma's commitment to establishing a strong foothold in-country to unlock value for our shareholders."

"To already have boots on the ground in the US will provide the Company with a key advantage over our competition. John has established relationships in the US market through his roles in California and Toronto and we look forward to leveraging his network in the coming months."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Fallers

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A worried man holds his head and look at his computer.
Share Fallers

Why 29Metals, Brainchip, Platinum, and Premier Investments shares are falling today

These ASX shares are having a tough time on hump day.

Read more »

Man with his head in his head because of falling share price.
Share Fallers

Why 29Metals, Atlas Arteria, IDP Education, and Mineral Resources shares are falling

These ASX shares are having a tough time on Tuesday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why ALS, EOS, NRW, and Patriot Battery Metals are dropping today

These ASX shares are starting the week in the red.

Read more »

A man looking at his laptop and thinking.
Technology Shares

Why are these ASX tech shares getting smashed today?

Owners of these two stocks are missing out today.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why AGL, Brickworks, IGO, and New Hope shares are dropping today

These ASX shares are having a poor session. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Amcor, Arafura, Brainchip, and South32 shares are tumbling today

These ASX shares are having a tough time on hump day. But why?

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Share Fallers

Why Aussie Broadband, Liontown, Metals Acquisition, and Seek shares are falling

These ASX shares are having a poor session. But why?

Read more »